| Patents for C07D 407 - Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group (11,963) |
|---|
| 06/08/2006 | US20060122183 Synergistic; side effect reduction; melanomas; toxicity; 2,5-Dimethoxythiobenzoic Acid N-methylhydrazine; anticancer |
| 06/08/2006 | US20060122126 (1S)-1,5-anhydro-1-[3-(1-benzothiene-2-ylmethyl)phenyl-D-glucitol and derivatives are Na+-glucose cotransporter inhibitors and are used to treat diabetes and related diseases such as insulin-resistance and obesity |
| 06/07/2006 | EP1663964A2 Method for the production of bisepoxides and dithiols |
| 06/07/2006 | EP1585725A4 Compounds which mimic the chemical and biological properties of discodermolide |
| 06/07/2006 | CN1784416A 9-ketospinosyn derivatives |
| 06/07/2006 | CN1781916A Cross-linked glycopeptide-cephalosporin antibiotics |
| 06/07/2006 | CN1258529C Process for preparing diaryl-4-amino-piperidinyl compounds |
| 06/06/2006 | US7056946 antitumor taxane containing a carboante group at c-10 position, benzoyoxy at c-2 position and hydroxy at c-7 position in the ring (c3o-c6-c6-c8) |
| 06/06/2006 | US7056903 Administering a therapeutical carbamate derivative to a patient as prostaglandin IP (12 or PGI2) antagonists |
| 06/06/2006 | CA2178974C Naphthalene derivatives, processes for the preparation thereof, and intermediates therefor |
| 06/01/2006 | WO2006058012A2 Gonadotropin releasing hormone receptor antagonists |
| 06/01/2006 | CA2587853A1 Gonadotropin releasing hormone receptor antagonists |
| 05/31/2006 | EP1661564A1 Heterocyclic compounds and their pharmaceutical use |
| 05/31/2006 | EP1345922B1 Pyrazole compounds useful as protein kinase inhibitors |
| 05/31/2006 | EP1318997B1 Pyrazole compounds useful as protein kinase inhibitors |
| 05/31/2006 | EP1317449B1 Pyrazole compounds useful as protein kinase inhibitors |
| 05/31/2006 | EP1317444B1 Pyrazole compounds useful as protein kinase inhibitors |
| 05/31/2006 | EP1163238B1 Chemokine recpetor binding heterocyclic compounds |
| 05/31/2006 | CN1780622A 4-(2-phenylsulfanyl-phenyl)-piperidine derivates as serotonin reuptake inhibitors |
| 05/30/2006 | US7053118 Therapeutic treatment of cancer, tumor with plakolide A, an alpha -exomethylene- gamma -disubstituted- gamma -lactone; an extracts of marine sponges of the family Plakinidae; stereospecfic |
| 05/30/2006 | US7053088 Vanilloid receptor ligands and their use in treatments |
| 05/26/2006 | WO2006054560A1 Aromatic amide derivatives, medicinal compositions containing the same, medical uses of both |
| 05/26/2006 | CA2588768A1 Aromatic amide derivatives, medicinal compositions containing the same, medical uses of both |
| 05/25/2006 | US20060111425 To treat diseases of respiratory, urinary and gastrointestinal systems; highly selective; significant potency; (2R,2S)(1 alpha ,5 alpha ,6 alpha )-N-{-[4-(1,3-dioxo-1,3-dihydro-isoindol-2-yl)-butyl]-3-azabicyclo[3.1.0]hex-6-yl-methyl}-2-hydroxy-2-cyclopentyl-2-phenylacetamide |
| 05/25/2006 | US20060111414 2-Amino-1-functionalized tetralin derivatives and related glycogen phosphorylase inhibitors |
| 05/25/2006 | US20060111413 2-Amino-3-functionalized tetralin derivatives and related glycogen phosphorylase inhibitors |
| 05/25/2006 | US20060111401 Taxanes having a C10 carbonate substituent |
| 05/24/2006 | CN1777582A Substituted indoline and indole derivatives |
| 05/24/2006 | CN1777421A Composition for oral administration containing alkylene dioxybenzene derivative |
| 05/23/2006 | US7049459 Chemical intermediate for rofecoxib, cyclooxygenase inhibitor |
| 05/23/2006 | CA2158454C Taxanes having furyl or thienyl substituted side-chain |
| 05/18/2006 | US20060106091 Antigiardial agents and use thereof |
| 05/18/2006 | US20060105961 Method of using a cox-2 inhibitor and a topoisomerase II inhibitor as a combination therapy in the treatment of neoplasia |
| 05/17/2006 | EP1656346A1 Novel substituted 3-sulfur indoles |
| 05/17/2006 | EP1345929B1 Pyrazole compounds useful as protein kinase inhibitors |
| 05/17/2006 | EP1345927B1 Pyrazole compounds useful as protein kinase inhibitors |
| 05/17/2006 | EP1345926B1 Pyrazole compounds useful as protein kinase inhibitors |
| 05/17/2006 | EP1345925B1 Pyrazole compounds useful as protein kinase inhibitors |
| 05/17/2006 | EP1317452B1 Pyrazole compounds useful as protein kinase inhibitors |
| 05/17/2006 | EP1317447B1 Pyrazole compounds useful as protein kinase inhibitors |
| 05/17/2006 | CN1774425A Quinazoline compounds |
| 05/17/2006 | CN1774417A A new process for the preparation of 17-phenyl-18, 19, 20-trinor-PGF2A and its derivatives |
| 05/11/2006 | WO2006050212A1 Substituted carboxylic acids |
| 05/11/2006 | US20060100225 Heteroaryl guanidines; inhibitors of viral replication |
| 05/11/2006 | CA2585550A1 Substituted carboxylic acids |
| 05/10/2006 | EP1654256A2 Tetrahydropyran heterocyclic cyclopentyl heteroaryl modulators of chemokine receptor activity |
| 05/10/2006 | EP1654247A1 Alkynyl aryl carboxamides |
| 05/10/2006 | EP1654244A1 3-aryl-4-hydroxyfuranone compounds and pharmaceutical and veterinary compositions containing them |
| 05/10/2006 | EP1653967A2 Combination of a cox-2 inhibitor and an alkylating-type antineoplastic agent for treatment of neoplasia |
| 05/10/2006 | EP1653944A1 Heterocyclic compounds useful as malonyl-coa decarboxylase inhibitors |
| 05/10/2006 | CN1770980A Pyrazoles and methods of making and using the same |
| 05/10/2006 | CN1255396C Carboxylic acid derivatives having fused rings |
| 05/10/2006 | CN1255380C Pyrrolecarboxamides and pyrrolethioamides as fungicides |
| 05/09/2006 | US7041838 (Meth)acrylate esters, starting alcohols for the preparation thereof, processes for preparing both, polymers of the esters, chemically amplifiable resist compositions, and method for forming patterns |
| 05/09/2006 | CA2233666C Heterocyclic fungicides |
| 05/04/2006 | WO2005118777A3 Novel saccharothrix strain and antibiotics derived therefrom, i.e. mutactimycins and aldgamycins |
| 05/04/2006 | US20060094902 Amino acid analogues |
| 05/04/2006 | US20060094758 N-substituted piperidine derivatives as serotonin receptor agents |
| 05/03/2006 | EP1651639A1 Benzofuran derivatives and their use in the treatment of microbial infections |
| 05/03/2006 | EP1651637A1 3-amino chroman and 2-amino tetralin derivatives |
| 05/03/2006 | EP1651592A2 Novel dibenzo[b,f]oxepine-10-carboxamides and pharmaceutical uses thereof |
| 05/03/2006 | EP1546128B1 Pyrimidine derivatives as selective cox-2 inhibitors |
| 05/03/2006 | EP1242400B1 Pyrrolidine derivatives as cyclic amp-specific phosphodiesterase inhibitors |
| 05/03/2006 | EP1194404B1 Inhibitors of aspartyl protease |
| 05/03/2006 | CN1768050A Benzopyran compounds useful for treating inflammatory conditions |
| 05/03/2006 | CN1767829A 4-(2-phenyloxyphenyl)-piperidine or -1,2,3,6-tetrahydropyridine derivatives as serotonin reuptake inhibitors. |
| 05/02/2006 | US7037940 Taxol enhancer compounds |
| 05/02/2006 | US7037524 Oral delivery of a botanical |
| 05/02/2006 | CA2263267C Process for the preparation of glycidyl ethers |
| 04/27/2006 | WO2006044955A1 Phosphodiesterase 4 inhibitors |
| 04/27/2006 | WO2006044528A1 Pyrazole derivatives as phosphodiesterase 4 inhibitors |
| 04/27/2006 | WO2006044412A1 Novel b1 bradykinin receptor antagonists |
| 04/27/2006 | CA2584328A1 Phosphodiesterase 4 inhibitors |
| 04/27/2006 | CA2584317A1 Pyrazole derivatives as phosphodiesterase 4 inhibitors |
| 04/27/2006 | CA2583267A1 Novel b1 bradykinin receptor antagonists |
| 04/26/2006 | CN1764655A Aromatic sulfone hydroxamates and their use as protease inhibitors |
| 04/26/2006 | CN1764651A Quinazoline derivatives as antitumor agents |
| 04/26/2006 | CN1764635A carboxylic acid compounds |
| 04/26/2006 | CN1253451C Novel indodyl oxazole compound and its preparation and application |
| 04/25/2006 | US7034035 Having a high residual activity, greater activity at lower application rates, curative activity, and a broader spectrum of efficacy; heterocyclic aromatic amides having a hydroxy group adjacent to the amide functionality |
| 04/25/2006 | US7034018 Substituted pyrrole mannich bases to combat pain and allergic reactions |
| 04/20/2006 | WO2006040568A1 Quinoxalines as b raf inhibitors |
| 04/20/2006 | WO2005016913A8 Tetrahydroisoquinoline or isochroman compounds as orl-1 receptor ligands for the treatment of pain and cns disorders |
| 04/20/2006 | US20060084819 Total synthesis of myriaporones |
| 04/20/2006 | US20060084688 Aromatic sulfone hydroxamic acid metalloprotease inhibitor |
| 04/20/2006 | CA2583096A1 Quinoxalines as b raf inhibitors |
| 04/19/2006 | EP1647545A1 Antiviral protease inhibitors |
| 04/19/2006 | EP1646623A2 5-h-benzo[d]naphth[2,1-b]azepine derivative as selective d1/d5 receptor antagonists for the treatment of obesity and cns disorders |
| 04/19/2006 | EP1646616A2 Combretastatin derivatives with cytotoxic action |
| 04/19/2006 | CN1761663A New heterocyclic compounds, a process for their preparation and their use as dyes and pigments |
| 04/19/2006 | CN1761662A Composition for promoting production of type I collagen and/or elastin |
| 04/19/2006 | CN1761657A EP4 receptor antagonists |
| 04/19/2006 | CN1760201A Method for preparing and purifying uperarin through membrane technology |
| 04/18/2006 | US7030130 Benzofuran derivatives and their use as antibacterial agents |
| 04/18/2006 | US7029849 Kit for use in the diagnosis of hypertension; obtain sample, determine pattern of alleles, detect preferential gene expression, preferential gene expression indicates hypertension |
| 04/18/2006 | US7029707 Method of producing a processed kava product having an altered kavalactone distribution and processed kava products produced using the same |
| 04/18/2006 | CA2148943C Oxidation of glycoside substituted taxanes to taxol or taxol precursors and new taxane compounds formed as intermediates |
| 04/13/2006 | US20060079575 Anticancer agent for drug resistant cancer |
| 04/13/2006 | US20060079572 Novel bioactive substance |
| 04/13/2006 | US20060079527 Compounds such as 1-[4-(3,4-difluoro-phenyl) -piperazin-1 -yl]-3-{methyl-[2-(9H-xanthen-9-yl)-ethyl]-amino}-propan-1 -one in free base or acid addition salt form, for therapy of depression, anxiety and bipolar disorders |